Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 33: 2024-2027, 1987;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teppo, A. M.
Right arrow Articles by Maury, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teppo, A. M.
Right arrow Articles by Maury, C. P.

Clinical Chemistry, Vol 33, 2024-2027, Copyright © 1987 by American Association for Clinical Chemistry

Radioimmunoassay of tumor necrosis factor in serum

AM Teppo and CP Maury
IV Department of Medicine, University Central Hospital, Helsinki, Finland.

We present a double-antibody radioimmunoassay for determination of the concentration of tumor necrosis factor (TNF) in serum. TNF in serum competes with a fixed amount of 125I-labeled TNF for the binding sites of specific rabbit antibodies. The bound TNF is precipitated with Sepharose-bound anti-rabbit IgG, then centrifuged, and the radioactivity of the pellets is counted. The detection limit of the assay is 7 ng/L (B0-3 SD). Bound radioactivity in the range of 10% to 90% of the B0 counts corresponds to TNF concentrations of 26 to 10,000 ng/L. Of 40 sera from healthy subjects, 21 (53%) contained TNF concentrations greater than 7 ng/L (range 8-40 ng/L). Some patients with parasitic or neoplastic disease and patients with septic shock had highly increased TNF values. Three of the 14 sera (21%) from patients with rheumatoid arthritis had TNF concentrations greater than 40 ng/L.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Juvonen, H.-M. Surcel, J. Satta, A.-M. Teppo, A. Bloigu, H. Syrjala, J. Airaksinen, M. Leinonen, P. Saikku, and T. Juvonen
Elevated Circulating Levels of Inflammatory Cytokines in Patients With Abdominal Aortic Aneurysm
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2843 - 2847.
[Abstract] [Full Text]

Home page
 Br J OphthalmolHome page
M. Vesaluoma, A.-M. Teppo, C. Gronhagen-Riska, and T. Tervo
Increased release of tumour necrosis factor-alpha in human tear fluid after excimer laser induced corneal wound
Br J Ophthalmol, February 1, 1997; 81(2): 145 - 149.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
M. Mintz, R. Rapaport, J. M. Oleske, E. M. Connor, M. R. Koenigsberger, T. Denny, and L. G. Epstein
Elevated Serum Levels of Tumor Necrosis Factor Are Associated With Progressive Encephalopathy in Children With Acquired Immunodeficiency Syndrome
Arch Pediatr Adolesc Med, July 1, 1989; 143(7): 771 - 774.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Association for Clinical Chemistry.